|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dockets
Management
|
|
|
Dockets Entered On June 13, 2003
TABLE OF CONTENTS (Linked)
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1977N-0094I
|
| Internal, Analgesic,
Antipyretic, and Antirheumatic Drug Pro
|
|
|
|
|
| 1978N-0021
|
| Skin Protectant
Drugs for OTC Human Use
|
|
|
|
|
| 1978N-0021P
|
| Skin Protectant
Drug Products for OTC Human Use
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center
for Food Safety & Applied Nutritin
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2003N-0079
|
| Consumer and
Producer Surveys on Economic Issues
|
|
|
|
|
| 2003N-0143
|
| Continued Over-the-Counter
Status of Ipecac Syrup
|
|
|
|
|
| 2003N-0168
|
| July 31, 2003
Public Meeting on Consumer Medication Information
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2003N-0202
|
| Agency
Information Collection Activities; Proposed Collection; Comment Request;
Assessment of Public Perceptions and Knowledge of Clinical Trials and
Informed Consent Human Subject Protection
|
|
|
|
|
|
|
|
|
| 2003N-0203
|
| Innovative Systems
for Delivery of Drugs and Biologics
|
|
|
|
|
| 2003P-0160
|
| FDA to send letter
ruling refusing to approve loratadine tab
|
|
|
|
|
| 2003P-0270
|
| Prohibit False
and Misleading Labeling
|
|
|
|
|
|
|
|
|
|
| CONTENTS
|
|
| 1977N-0094I
|
| Internal,
Analgesic, Antipyretic, and Antirheumatic Drug Pro
|
|
|
|
|
|
|
| NPR
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 1978N-0021
|
| Skin
Protectant Drugs for OTC Human Use
|
|
|
|
|
|
|
| BKG 1
|
| background Material
Refs 1- 104
|
| Vol #:
|
| 45
|
|
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 45
|
|
|
|
|
| 1978N-0021P
|
| Skin
Protectant Drug Products for OTC Human Use
|
|
|
|
|
|
|
| BKG 1
|
| Background (Refs
1 - 104)
|
| Vol #:
|
| 3
|
|
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 3
|
|
|
|
|
| 1998N-0359
|
| Program
priorities/Center for Food Safety & Applied Nutritin
|
|
|
|
|
|
|
| N
5
|
| FDA
|
| Vol #:
|
| 7
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin
for Poultry: Opportunity for Hearing
|
|
|
|
|
|
|
|
|
| EXB 9
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 10
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 11
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 12
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 13
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 14
|
| Center for Veterinary
Medicine
|
| Vol #:
|
| 378
|
|
| | | | | | | | |
|
|
|
|
| EXB 15
|
| Center for Veterinary Medicine
|
| Vol #:
|
| 378
|
|
|
|
|
| EXB 16
|
| Bayer Corporation
|
| Vol #:
|
| 378
|
|
|
|
|
| 2002N-0204
|
| Bar Code
Label Requirements for human drug products
|
|
|
|
|
|
|
|
|
| EC 85
|
| Weakland, Rosalie
|
| Vol #:
|
| 17
|
|
|
|
|
| 2003N-0079
|
| Consumer and Producer Surveys on Economic Issues
|
|
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0143
|
| Continued
Over-the-Counter Status of Ipecac Syrup
|
|
|
|
|
|
|
| C 2
|
| Jerome S. Fink
|
| Vol #:
|
| 1
|
|
|
|
|
| C 3
|
| Debbie Begeny
|
| Vol #:
|
| 1
|
|
|
|
|
| C 4
|
| Patricia M. Coppola
|
| Vol #:
|
| 1
|
|
|
|
|
| C 5
|
| David R. Kraus, MD
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0168
|
| July 31, 2003 Public Meeting on Consumer Medication Information
|
|
|
|
|
|
|
| BKG
1
|
| Reference List for Public Meeting (Refs 1 - 3)
|
| Vol #:
|
| 1
|
|
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0169
|
| Dental
Amalgam; Request for Information
|
|
|
|
|
|
|
| C 5
|
| Kevin B. Cook, DDS., SC
|
| Vol #:
|
| 1
|
|
|
|
|
| C 6
|
| Hal A. Huggins, DDS, MS
|
| Vol #:
|
| 1
|
|
|
|
|
| SUP 5
|
| Cornelius K. Blesius, MD
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0202
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Assessment of Public Perceptions and Knowledge of Clinical Trials and Informed Consent Human Subject Protection
|
|
|
|
|
|
|
|
|
|
|
| BKG
1
|
| Draft Survey
|
| Vol #:
|
| 1
| Word
Html
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0203
|
| Innovative Systems for Delivery of Drugs and Biologics
|
|
|
|
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0160
|
| FDA to send letter ruling refusing to approve loratadine tab
|
|
|
|
|
|
|
|
|
| C
3
|
| L. Perrigo Company (Perrigo)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
|
|
|
|
| ACK
1
|
| HFA-305 To Compassion Over Killing, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Compassion Over Killing, Inc
|
| Vol #:
|
| 1
| Additional Materials
Exhibit
3
Exhibit
4
Exhibit
5
Exhibit
6
Exhibit
7
Exhibit
8
Exhibit
11a
Exhibit
11b
Exhibit
14
Exhibit
15
|
|
|
|
| 2003V-0130
|
| Laser
Light Show
|
|
|
|
|
|
